Human Papilloma Virus (HPV) Vaccine Overview Categories 19 Immunologicals19.3 Vaccines19.3.1 Vaccines for universal immunization Page headings Overview Primary Characterstics Indications Pharmacokinetics Contraindications Drug Interactions Side Effects Dosage High Risk Groups Warning / Precautions Storage Conditions Interference in Pathology Brands of Cisapride Manufacturers of Cisapride Primary Characterstics Indications Back to top Pharmacokinetics Back to top Contraindications Back to top Drug Interactions Back to top Side Effects Back to top Dosage Cisapride's dosage details are as follows: Dose Single Dose Frequency Route Instructions Adult Dosage 0.5 mL0.5 (0.5)As recommended.IMBetween 10 to 25 years for prevention of cervical cancer.0.5 mL0.5 (0.5)As recommended.IMUsual Adult Dose for Human Papillomavirus Prophylaxis: Repeat dose in 2 months and 6 months for a total of 3 doses. (Between 9 to 26 years) Paedriatic Dosage (20kg) No data regarding the Paedriatic dosage details of Cisapride is available. Neonatal Dosage (3kg) No data regarding the neonatal dosage details of Cisapride is available. High Risk Groups Back to top Warning / Precautions Back to top Storage Conditions Back to top Interference in Pathology Back to top Brands / Trade Names of Cisapride Back to top Manufacturers of Human Papilloma Virus (HPV) Vaccine in Pakistan GSK Back to top Previous Drug Generic - Next Drug Generic
Human Papilloma Virus (HPV) Vaccine Overview Categories 19 Immunologicals19.3 Vaccines19.3.1 Vaccines for universal immunization Page headings Overview Primary Characterstics Indications Pharmacokinetics Contraindications Drug Interactions Side Effects Dosage High Risk Groups Warning / Precautions Storage Conditions Interference in Pathology Brands of Cisapride Manufacturers of Cisapride Primary Characterstics Indications Back to top Pharmacokinetics Back to top Contraindications Back to top Drug Interactions Back to top Side Effects Back to top Dosage Cisapride's dosage details are as follows: Dose Single Dose Frequency Route Instructions Adult Dosage 0.5 mL0.5 (0.5)As recommended.IMBetween 10 to 25 years for prevention of cervical cancer.0.5 mL0.5 (0.5)As recommended.IMUsual Adult Dose for Human Papillomavirus Prophylaxis: Repeat dose in 2 months and 6 months for a total of 3 doses. (Between 9 to 26 years) Paedriatic Dosage (20kg) No data regarding the Paedriatic dosage details of Cisapride is available. Neonatal Dosage (3kg) No data regarding the neonatal dosage details of Cisapride is available. High Risk Groups Back to top Warning / Precautions Back to top Storage Conditions Back to top Interference in Pathology Back to top Brands / Trade Names of Cisapride Back to top Manufacturers of Human Papilloma Virus (HPV) Vaccine in Pakistan GSK Back to top Previous Drug Generic - Next Drug Generic